Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS). [PDF]
Blood AdvZhang E +12 more
europepmc +1 more source
Immunodeficiency Diseases and Tumor Immunobiology [PDF]
, 1974 Abramoff, Peter A., Duquesnoy, Rene J.
core +1 more source
Hereditary hemorrhagic telangiectasia in a 68-year-old man. [PDF]
CMAJChen LL, Xie W.
europepmc +1 more source
Severe retinopathy induced by low-dose tamoxifen: a 10-month follow-up analysis based on multimodal imaging. [PDF]
BMC OphthalmolZhang S +5 more
europepmc +1 more source
Promising Results With NAD Supplementation in Rare Diseases With Premature Aging and DNA Damage. [PDF]
Aging CellBohr VA.
europepmc +1 more source
Modulating <i>ACVRL1</i> Expression in HMEC1 Cells as a Simplified <i>In Vitro</i> Model for Hereditary Hemorrhagic Telangiectasia (HHT) Type 2 Studies. [PDF]
In VivoRusche JR +5 more
europepmc +1 more source
The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic Telangiectasia. [PDF]
CureusAydın Ö +10 more
europepmc +1 more source
Response by Boström and Yao to Letter Regarding Article, "Arterial-Lymphatic-Like Endothelial Cells Appear in Hereditary Hemorrhagic Telangiectasia 2 and Contribute to Vascular Leakage and Arteriovenous Malformations". [PDF]
CirculationBoström KI, Yao Y.
europepmc +1 more source
An Uncommon Cause of Massive Hemothorax: Pulmonary Arteriovenous Malformation in the Right Middle Lobe. [PDF]
Open Respir ArchÁlvarez Albarrán J +2 more
europepmc +1 more source